Abstract
There is growing evidence that conventional chemotherapeutics can modulate the immune system and trigger an immune response which sustains a long term durable therapeutic outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Galluzzi, L., Senovilla, L., Zitvogel, L., Kroemer, G.: The secret ally: immunostimulation by anticancer drugs. Nat. Rev. Drug Discov. 11, 215–233 (2012)
Zitvogel, L., Galluzzi, L., Smyth, M.J., Kroemer, G.: Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39, 74–88 (2013)
Mattarollo, S.R., Loi, S., Duret, H., Ma, Y., Zitvogel, L., Smyth, M.J.: Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res. 71, 4809–4820 (2011)
Halama, N., Michel, S., Kloor, M., Zoernig, I., Benner, A., Spille, A., Pommerencke, T., von Knebel, D.M., Folprecht, G., Luber, B., Feyen, N., Martens, U.M., Beckhove, P., Gnjatic, S., Schirmacher, P., Herpel, E., Weitz, J., Grabe, N., Jaeger, D.: Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer Res. 71, 5670–5677 (2011)
Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.: Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann. Oncol. 25, 611–618 (2014)
Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L.: Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51–72 (2013)
Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P.: Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860–875 (2012)
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G.M., Apetoh, L., Perfettini, J.L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Metivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., Kroemer, G.: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54–61 (2007)
Menger, L., Vacchelli, E., Adjemian, S., Martins, I., Ma, Y., Shen, S., Yamazaki, T., Sukkurwala, A. Q., Michaud, M., Mignot, G., Schlemmer, F., Sulpice, E., Locher, C., Gidrol, X., Ghiringhelli, F., Modjtahedi, N., Galluzzi, L.; André, F., Zitvogel, L., Kepp, O., Kroemer, G.: Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci. Transl. Med. 4, 143ra99 (2012)
Kepp, O., Menger, L., Vacchelli, E., Locher, C., Adjemian, S., Yamazaki, T., Martins, I., Sukkurwala, A.Q., Michaud, M., Senovilla, L., Galluzzi, L., Kroemer, G., Zitvogel, L.: Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev. 24, 311–318 (2013)
Chao, M.P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A.A., Gentles, A.J., Volkmer, J., Weiskopf, K., Willingham, S.B., Raveh, T., Park, C.Y., Majeti, R., Weissman, I.L.: Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2, 63ra94 (2010)
Tesniere, A., Schlemmer, F., Boige, V., Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., Mendiboure, J., Pignon, J.P., Jooste, V., van Endert, P., Ducreux, M., Zitvogel, L., Piard, F., Kroemer, G.: Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29, 482–491 (2009)
Shah, N., Dizon, D.S.: New-generation platinum agents for solid tumors. Future Oncol. 5, 33–42 (2009)
Park, G.Y., Wilson, J.J., Song, Y., Lippard, S.J.: Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile. Proc. Natl. Acad. Sci. U. S. A. 109, 11987–11992 (2012)
Bhargava, A., Vaishampayan, U.N.: Satraplatin: leading the new generation of oral platinum agents. Expert Opin. Investig. Drugs 18, 1787–1797 (2009)
Holford, J., Sharp, S.Y., Murrer, B.A., Abrams, M., Kelland, L.R.: In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Br. J. Cancer 77, 366–373 (1998)
Zou, T., Lok, C.N., Fung, Y.M., Che, C.M.: Luminescent organoplatinum(II) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity. Chem. Commun. 49, 5423–5425 (2013)
Hoffmann, P.R., deCathelineau, A.M., Ogden, C.A., Leverrier, Y., Bratton, D.L., Daleke, D.L., Ridley, A.J., Fadok, V.A., Henson, P.M.: Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155, 649–659 (2001)
Savill, J., Dransfield, I., Gregory, C., Haslett, C.: A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965–975 (2002)
Gardai, S.J., McPhillips, K.A., Frasch, S.C., Janssen, W.J., Starefeldt, A., Murphy-Ullrich, J.E., Bratton, D.L., Oldenborg, P.-A., Michalak, M., Henson, P.M.: Cell-Surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321–334 (2005)
Garg, A., Krysko, D., Vandenabeele, P., Agostinis, P.: Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother. 61, 215–221 (2012)
Garg, A.D., Krysko, D.V., Verfaillie, T., Kaczmarek, A., Ferreira, G.B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A.J.M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., Agostinis, P.: A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062–1079 (2012)
Garg, A.D., Krysko, D.V., Vandenabeele, P., Agostinis, P.: The emergence of phox-ER stress induced immunogenic apoptosis. OncoImmunology 1, 786–788 (2012)
Inoue, H., Tani, K.: Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ. 21, 39–49 (2014)
Hempel, S.L., Buettner, G.R., O’Malley, Y.Q., Wessels, D.A., Flaherty, D.M.: Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 27, 146–159 (1999)
Costes, S.V., Daelemans, D., Cho, E.H., Dobbin, Z., Pavlakis, G., Lockett, S.: Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993–4003 (2004)
Wang, X., Olberding, K.E., White, C., Li, C.: Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ. 18, 38–47 (2011)
Sukkurwala, A.Q., Adjemian, S., Senovilla, L., Michaud, M., Spaggiari, S., Vacchelli, E., Baracco, E.E., Galluzzi, L., Zitvogel, L., Kepp, O., Kroemer, G.: Screening of novel immunogenic cell death inducers within the NCI mechanistic diversity set. OncoImmunology 3, e28473 (2014)
Wong, D.Y.Q., Yeo, C.H.F., Ang, W.H.: Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents. Angew. Chem. Int. Ed. 53, 6752–6756 (2014)
Dhara, S.C.: A rapid method for the synthesis of cis-[Pt(NH3)2Cl2]. Indian J. Chem. 8, 193–194 (1970)
Pepels, A., Rauter, H., Schnebeck, R.D., Wissmann, F.: Process for the preparation of 1,2-diaminocyclohexane-platinum(II) complexes. In Google Patents (2007)
Chin, C.F., Tian, Q., Setyawati, M.I., Fang, W., Tan, E.S., Leong, D.T., Ang, W.H.: Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation. J. Med. Chem. 55, 7571–7582 (2012)
Zhang, J.Z., Bonnitcha, P., Wexselblatt, E., Klein, A.V., Najajreh, Y., Gibson, D., Hambley, T.W.: Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design. Chem. Eur. J. 19, 1672–1676 (2013)
Battle, A.R., Choi, R., Hibbs, D.E., Hambley, T.W.: Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies. Inorg. Chem. 45, 6317–6322 (2006)
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Supplementary Information
Supplementary Figures
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wong, D.Y.Q. (2018). Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes. In: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches. Springer Theses. Springer, Singapore. https://doi.org/10.1007/978-981-10-8594-9_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-8594-9_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8593-2
Online ISBN: 978-981-10-8594-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)